Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1560 participants
OBSERVATIONAL
2016-05-23
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
calcipotriol/betamethasone dipropionate gel in Applicator
Topical treatment of scalp using applicator device. The study as such is non-interventional as the intervention has been decided prior to and independently from the inclusion of the patient in the cohort to be observed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dermatologist or general practitioner has decided to initiate treatment with Daivobet® gel Applicator
Exclusion Criteria
* Contraindication for treatment with calcipotriol or betamethasone dipropionate
* Informed consent to participate in the study has not been obtained
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LEO Pharma
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mathilde Kemula, MD
Role: PRINCIPAL_INVESTIGATOR
Cabinet de Dermatologie, Dr. Mathilde Kemula
Frederic Bonnier, MD
Role: PRINCIPAL_INVESTIGATOR
General Practice, 356 Rue de Charles de Gaulle, 91400 Orsay
Nathalie Quiles, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Saint Joseph, 26 Boulevard de Louvain, Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cabinet de Dermatologie, Dr. Mathilde Kemula
Charenton-le-Pont, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67-74. doi: 10.1097/00005650-198601000-00007.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-DAIVOBETGEL-1284
Identifier Type: -
Identifier Source: org_study_id